A project from the American Society of Retina SpecialistsSign in to view content
Phase III Randomized Clinical Trial Comparing SB15 With Reference Aflibercept in Neovascular Age-Related Macular Degeneration 56-Week Results
- Video
- Published 2023
Related
Category: AMD-Neovascular